Biote Corp. - Class A Common Stock BTMD 深 滬
交易中 09-20 12:37:43 美东时间
6.00
-0.110
-1.80%
華盛通- 最 高6.13
- 今 開6.13
- 成交量 8.31万股
- 最 低 5.95
- 昨 收 6.11
- 總市值 2.14亿
- 52周最高 8.44
- 市盈率 靜 46.51
- 換手率 0.23%
- 52周最低 3.6538
- 委 比 -60.00%
- 總股本 3571.25万
- 歷史最高 12.08
- 量 比 1.17
- 振 幅 2.95%
- 歷史最低 2.75
- 每 手 1
- 風險率 1.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Analysts Are Bullish on These Healthcare Stocks: biote (BTMD), Ardent Health Partners, Inc. (ARDT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-16 07:00
BIOTE reports Q2 GAAP EPS of -$0.19
BIOTE press release (NASDAQ:BTMD): Q2 GAAP EPS of -$0.19. Revenue of $49.2 million. Procedure revenue of $38.4 million. Gross profit margin of 68.9%, including a $1.2 million inventory step-up related...
08-09 20:22
Biote Corp. Announces Strategic Sales Head Departure and Compensation Package
The latest update is out from biote (BTMD). Biote Corp. recently announced the ...
07-04 04:29
Biote announces $60 million agreement to repurchase 8.3 million shares
biote corp (NASDAQ: BTMD) signed a binding term sheet with Marci M. Donovitz, stockholder of Biote, to resolve litigation. For $60M in the aggregate, Biote will repurchase all the approximately 8.3M o...
06-21 05:04
PTC Therapeutics, Oragenics, GT Biopharma among healthcare movers
Gainers: GT Biopharma (GTBP) +180%. Oragenics (OGEN) +39%. Dyne Therapeutics (DYN) +22%. NKGen Biotech (NKGN) +24%. PTC Therapeutics (PTCT) +21%. Losers: Lucy Scientific Discovery (LSDI) -18%. biote (...
05-20 22:00
ASTS, LSDI and BTMD among pre-market losers
Losers: FLJ Group Ltd (FLJ) -27%. Syra Health Corp (SYRA) -11%. iPower (IPW) -11%. Lucy Scientific Discovery (LSDI) -10%. AST Space Mobile (ASTS) -8%. MDJM Ltd (MDJH) -9%. Bit Origin Ltd (BTOG) -8%. A...
05-20 20:20
Biote Reiterates Guidance
2024 Financial Outlook"Based on our solid first quarter financial performance and our expectations for stronger revenue growth in the second half of the year, we reaffirm our 2024 financial guidance," concluded Ms.
05-08 06:15
Biote Settles Litigation and Repurchases Shares from Founder
biote (BTMD) has shared an announcement. Biote Corp. has reached a settlement w...
04-30 04:32
Biote Reaffirms 2024 Financial Guidance, With Acceleration In H2 Growth; Sees Revenue Of $200M-$204M, Est $203.167M; Adjusted EBITDA Of $60M-$63M
Previously, Biote projected fiscal 2024 revenue of greater than $200 million and Adjusted EBITDA of greater than $60 million. First half 2024 consolidated year-on-year revenue growth is expected to be in
03-13 04:52
Biote: Q4 Earnings Insights
Biote (NASDAQ:BTMD) reported its Q4 earnings results on Tuesday, March 12, 2024...
03-13 04:15
